What i would like to know about leflunomide
Kremer, J.M.
Journal of Rheumatology 31(6): 1029-1031
2004
ISSN/ISBN: 0315-162X PMID: 15170910 Document Number: 568544
Document emailed within 1 workday
Related Documents
Hirohata, S. 2002: Efficacy of leflunomide Nihon Rinsho. Japanese Journal of Clinical Medicine 60(12): 2357-2363Kaplan, M.J. 2001: Leflunomide Aventis Pharma Current Opinion in Investigational Drugs 2(2): 222-230
Marques Filho, J. 2016: Hypogeusia as a side effect of leflunomide Acta Reumatologica Portuguesa 41(1): 88-89
Martin, N.; Innes, J.A.; Lambert, C.M.; Turnbull, C.M.; Wallace, W.A.H. 2007: Hypersensitivity pneumonitis associated with leflunomide therapy Journal of Rheumatology 34(9): 1934-1937
El Aïdli, S.; Salouage, I.; Kastalli, S.; Srairi, S.; Daghfous, R.; Loueslati, M.H.éd.; Belkahia, C. 2008: Leflunomide-induced toxic epidermal necrolysis Therapie 63(2): 157-158
Bloudícková, S.; Rajnoch, J.; Lodererová, A.; Honsová, E.; Viklický, O. 2010: Leflunomide derivate FK 778 in accelerated renal injury in transgenic rat Folia Biologica 56(2): 72-77
Banas, T.; Hadyla-Banas, I.; Pityński, K.; Bereza, K.; Migdal, M.; Batko, B. 2014: Use of contraception by women treated with leflunomide due to rheumatic arthritis Journal of Obstetrics and Gynaecology: the Journal of the Institute of Obstetrics and Gynaecology 34(1): 60-64
Nousari, H.C.; Anhalt, G.J. 2000: Bullous pemphigoid treated with leflunomide: a novel immunomodulatory agent Archives of Dermatology 136(10): 1204-1205
Zhang, G.-L.; Huang, F.; Zhang, J.-L.; Li, X.-F. 2009: A clinical study of leflunomide and methotrexate therapy in psoriatic arthritis Zhonghua Nei Ke Za Zhi 48(7): 570-574
Godinho, F.; Godfrin, B.; El Mahou, S.; Navaux, F.; Zabraniecki, L.; Cantagrel, A. 2004: Safety of leflunomide plus infliximab combination therapy in rheumatoid arthritis Clinical and Experimental Rheumatology 22(3): 328-330
Lin, Y.; Vandeputte, M.; Waer, M. 1995: Effect of leflunomide and cyclosporine on the occurrence of chronic xenograft lesions Kidney International. Supplement 52: S23-S28
Osiri, M.; Shea, B.; Robinson, V.; Suarez-Almazor, M.; Strand, V.; Tugwell, P.; Wells, G. 2003: Leflunomide for the treatment of rheumatoid arthritis: a systematic review and metaanalysis Journal of Rheumatology 30(6): 1182-1190
Ulrichs, K.; Kaitschick, J.; Bartlett, R.; Müller-Ruchholtz, W. 1992: Suppression of natural xenophile antibodies with the novel immunomodulating drug leflunomide Transplantation Proceedings 24(2): 718-719
Koenig, A.S.; Abruzzo, J.L. 2002: Leflunomide induced fevers, thrombocytosis, and leukocytosis in a patient with relapsing polychondritis Journal of Rheumatology 29(1): 192-194
Shastri, V.; Betkerur, J.; Kushalappa, P.A.; Savita, T.G.; Parthasarathi, G. 2006: Severe cutaneous adverse drug reaction to leflunomide: a report of five cases Indian Journal of Dermatology Venereology and Leprology 72(4): 286-289
Grzywa, M.; Kadziela, M.łg. 2013: The conversion of hypothyroidism into hyperthyroidism during leflunomide with povidone iodine treatment of rheumatoid arthritis Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 34(204): 348-350
Novak, S. 2008: The efficacy and safety of the combination of leflunomide (Arava) and biological agents in treatment of rheumatoid arthritis Reumatizam 55(2): 68-69
Fujimura, H. 1998: Molecular cloning of Saccharomyces cerevisiae MLF4/SSH4 gene which confers the immunosuppressant leflunomide resistance Biochemical and Biophysical Research Communications 246(2): 378-381
Hausen, B.; Boeke, K.; Berry, G.J.; Gummert, J.F.; Christians, U.; Morris, R.E. 1999: Potentiation of immunosuppressive efficacy by combining the novel leflunomide analog, HMR 279, with microemulsion cyclosporine in a rat lung transplant model Transplantation 67(3): 354-359
Lucien, J.; Marath, A.; Rayat, G.; Thliveris, J.; Koshal, A.; Yatscoff, R. 1996: Efficacy of leflunomide to reduce xenoantibody titers in vivo: an evaluation of the prolongation of discordant xenograft survival Transplantation Proceedings 28(2): 704-707